Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Wang H, Liu K, Geng M, Gao P, Wu X, Hai Y, et al
Introduction The Growing Demand for GLP-1 Therapies Current Manufacturing Challenges The Future of GLP-1 Manufacturing Conclusions With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet growing needs efficiently
We estimated the insulin resistance by using Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) equation as described by Matthews et al
The IRB approval number is 2021KYLL032
US$ 25.78
US$ 23.98
US$ 20.14
US$ 25.72
US$ 21.36
US$ 27.42
US$ 21.17
US$ 26.15
US$ 21.29
US$ 20.90
US$ 26.68
US$ 21.08
US$ 23.57
US$ 24.62
US$ 25.45
US$ 20.49
US$ 25.41
US$ 29.06
